Related Experiment Video
Updated: Jul 19, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Multiple myeloma involving the thyroid cartilage.
Taketoshi Shimada1, Masahiro Matsui, Kaichiro Ikebuchi
1Department of Otolaryngology, Head and Neck Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-0841, Japan. tshimada@koto.kpu-m.ac.jp
Auris, Nasus, Larynx
|November 7, 2006
Summary
This study details a rare case of multiple myeloma affecting the thyroid cartilage in a 72-year-old male. The patient successfully responded to irradiation without adjuvant therapy, showing no disease progression over three years.
Area of Science:
- Oncology
- Hematology
- Laryngology
Background:
- Plasma cell neoplasms, including multiple myeloma, present a spectrum of disease.
- Extramedullary plasmacytoma in the larynx is uncommon, particularly involving the thyroid cartilage.
Observation:
- A 72-year-old male presented with a pathological cervical vertebrae fracture.
- CT revealed low-density lesions within the thyroid cartilage, with intact laryngeal mucosa.
- Tumors in the thyroid cartilage and vertebrae showed plasmacytoma, leading to a multiple myeloma diagnosis.
Findings:
- The patient received irradiation for laryngeal and cervical vertebrae lesions.
- No aggressive changes or new lesions were observed during a 3-year follow-up.
- The treatment was effective without the need for adjuvant therapy.
Implications:
- This case highlights the possibility of thyroid cartilage involvement in multiple myeloma.
- It underscores the effectiveness of localized irradiation for rare plasmacytoma presentations.
- Further research may elucidate optimal management strategies for laryngeal plasma cell neoplasms.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...